Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study
about
Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Feasibility of sequential adju ...... orectal cancer: JSWOG-C2 study
@en
Feasibility of sequential adju ...... rectal cancer: JSWOG-C2 study.
@nl
type
label
Feasibility of sequential adju ...... orectal cancer: JSWOG-C2 study
@en
Feasibility of sequential adju ...... rectal cancer: JSWOG-C2 study.
@nl
prefLabel
Feasibility of sequential adju ...... orectal cancer: JSWOG-C2 study
@en
Feasibility of sequential adju ...... rectal cancer: JSWOG-C2 study.
@nl
P2093
P2860
P356
P1476
Feasibility of sequential adju ...... orectal cancer: JSWOG-C2 study
@en
P2093
Akihito Tsuji
Atsushi Tsuruta
Hiroaki Tanioka
Kazuhiro Toyota
Kazuki Yamashita
Masanori Yoshimitsu
Masazumi Okajima
Michio Inukai
Taketoshi Yamano
Tomoki Yamatsuji
P2860
P304
P356
10.2147/DDDT.S112322
P407
P577
2016-11-23T00:00:00Z